The antioxidant and the inhibition capacity of two brain enzymes, cholinesterases (AChE and BuChE), involved in the pathogenesis of Alzheimer’s disease, were also evaluated in the final prototypes. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.